Precision Diagnostics being the “Largest Clinical Accredited Genome-Wide Pharmacogenomics Campaign 2025” and the “First Clinical Recommended for Genome-Wide Pharmacogenomics 2023”
Fill in your contact details and our team will reach you soon.
Our team at Precision Diagnostics will carefully review the following queries. Our scientific collaborations empower the development of groundbreaking tools and technologies that push the boundaries of discovery to Advancing Tomorrow's Cures.
Click here and follow the instructions! Once finished, place the sample in the hazard bag and return to your respective PIC (person-in-charge).
Pharmacogenomics (PGx), a core component in Precision Medicine, is the study of how genes affect a person’s response to medications. This field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications that can be prescribed based on a person’s genetic makeup while preventing medications’ side effects (known as Adverse Drug Reactions, ADRs). In other words, a medication can be safe for one but harmful for the other, even when prescribed with similar doses.
This test is open to the general public.
While there are no age restrictions for Pharmacogenomic (PGx) tests. For individuals below the age of 18, a legal guardian must complete the request and consent form. In the case of children, their phenotype (DNA traits) remains the same, but medication doses might change as they grow.
With an analytical accuracy and reliability of over 99%, our genome-wide platform has proven to be highly precise and dependable. The clinical recommendations in our report are accredited by the Health Science Authority (HSA) of Singapore – HSA Class A Medical Device, NQA (National Quality Assurance Limited) accredited by UKAS (United Kingdom Accreditation Service) for ISO13485 certified; while our laboratory operations strictly adhere to the standards set by CAP and ISO 15189.
In Malaysia, the rising prevalence of chronic diseases like diabetes, heart disease, and cancer is a growing concern. Many Malaysians are battling these severe conditions daily, often relying on medications that may not work optimally for everyone. But what if there was a way to tailor your treatment to your unique genetic makeup?